Warner Chilcott Falsely Promoted Drugs, FCA Suit Says

Law360, New York (February 22, 2013, 5:49 PM EST) -- Warner Chilcott PLC overstated its osteoporosis drugs' effectiveness and paid kickbacks to doctors to induce them to prescribe the medications, resulting in the overbilling of Medicare and Medicaid, according to an employee’s False Claims Act suit unsealed Thursday by a Massachusetts federal judge.

According to relator Chris Wible, a Warner Chilcott sales representative, the drugmaker had illegally promoted its osteoporosis treatments Actonel and Atelvia as superior to cheaper competitors, despite lacking any significant clinical evidence, as well as for off-label use. The company then doubled down on its...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.